Tag Archives: VRX

Hot Canadian Stocks To Own Right Now

Cathie Wood-led firm Ark Investment Management has revised the prospectus for its ARK Next Generation Internet ETF (ARKW) to open the possibility of investing in crypto exchange-traded funds (ETFs) in Canada. 

What Happened: According to the filling with the U.S. Securities and Exchange Commission (SEC), the fund may invest in the Grayscale Bitcoin Trust (GBTC) or “other pooled investment vehicles that invest in bitcoin (CRYPTO: BTC), such as exchange-traded funds that are domiciled and listed for trading in Canada (Canadian Bitcoin ETFs).” 

In a recent tweet, Bloomberg ETF analyst Eric Balchunas speculated that Ark was looking to replace ARKW’s investment in GBTC with a Canadian ETF.

He said, “INTERESTING: ARK just amended the prospectus for $ARKW to say the fund may invest in crypto ETFs in Canada. My guess is they looking to swap out $GBTC, which they own $350m worth for one of the Canadian ETFs, which tracks better. $BLOK just did this.”

He also mentioned that GBTC is down 22% year-to-date, while the Canadian ETF has dropped 6%. “That’s pretty significant dispersion,” he wrote. “I’m sure that’s irking them.”

Hot Canadian Stocks To Own Right Now: Natural Gas(NG)

NovaGold Resources Inc., through its subsidiaries, engages in the exploration and development of mineral properties primarily in North America. The company primarily explores for gold, silver, copper, zinc, and lead ores. It holds interests in the Donlin Creek property covering 81,361 acres and the Ambler property comprising 90,614 acres located in Alaska; and the Galore Creek property comprising 293,838 acres located in northwestern British Columbia, Canada. The company was formerly known as NovaCan Mining Resources (1985) Limited and changed its name to NovaGold Resources Inc. in March 1987. NovaGold Resources Inc. was founded in 1984 and is based in Vancouver, Canada.

Advisors’ Opinion:

  • [By ]

    The Paulson & Co. 13F showed that it held 40 stocks at the end of the second quarter. Its largest position is drug manufacturer Bausch Health Companies (BHC), accounting for 18.2% of its overall portfolio. In addition, Paulson owns large positions in several gold producers, the biggest being NovaGold Resources (NG).

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Novagold Resources (NG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Canadian Stocks To Own Right Now: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) has a PDUFA action date set for October 5 for its Jemdel (halobetasol propionate 0.01%) (IDP-122) lotion. If approved, Jemdel will be the first high-potency topical steroid treatment for plaque psoriasis with dosing for as long as eight weeks.

  • [By Shane Hupp]

    Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Valeant Pharmaceuticals Intl (VRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Canadian Stocks To Own Right Now: Sensata Technologies Holding N.V.(ST)

Sensata Technologies Holding N.V., through its subsidiaries, develops, manufactures, and sells sensors and controls primarily in the Americas, the Asia Pacific, and Europe. It operates in two segments, Sensors and Controls. The Sensors segment offers pressure sensors, force sensors, temperature sensors, speed sensors, position sensors, motor protectors, and thermal and magnetic-hydraulic circuit breakers and switches. Its sensors are used in various applications, such as automotive air-conditioning, braking, transmission, air bag, heavy vehicle off-road, industrial, aerospace, defense, and data/telecom applications, as well as heating, ventilation, and air-conditioning (HVAC) applications. The Controls segment provides bimetal electromechanical controls, thermal and magnetic-hydraulic circuit breakers, power inverters, and interconnection products. This segment also offers application-specific products, including motor and compressor protectors, circuit breakers, semicondu ctor burn-in test sockets, electrical HVAC controls, power inverters, precision switches, and thermostats. Its products are used in heating and air-conditioning systems, refrigerators, aircraft, automobiles, and light industrial system applications in industrial, aerospace, military, commercial, and residential markets. The company offers its products primarily under the Sensata, Klixon, Airpax, and Dimensions brand names. It serves original equipment manufacturers and suppliers in the automotive, industrial, and commercial end-markets; and industrial and commercial manufacturers and suppliers in the climate control, appliance, semiconductor, datacomm, telecommunications, and aerospace industries, as well as motor and compressor suppliers. The company was founded in 1916 and is based in Almelo, the Netherlands. Sensata Technologies Holding N.V. is a subsidiary of Sensata Investment Company S.C.A.

Advisors’ Opinion:

  • [By Max Byerly]

    Sensata Technologies (NYSE:ST) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $3.94-4.10 for the period, compared to the Thomson Reuters consensus estimate of $4.05. The company issued revenue guidance of $3.58-3.68 billion, compared to the consensus revenue estimate of $3.63 billion.Sensata Technologies also updated its FY 2019 guidance to $3.94-4.10 EPS.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Sensata Technologies (ST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    ValuEngine downgraded shares of Sensata Technologies (NYSE:ST) from a hold rating to a sell rating in a report issued on Thursday morning.

    Several other equities analysts have also issued reports on ST. Zacks Investment Research lowered Sensata Technologies from a buy rating to a hold rating in a research note on Thursday, June 28th. Canaccord Genuity initiated coverage on Sensata Technologies in a research report on Friday, August 3rd. They set a buy rating and a $70.00 target price on the stock. JPMorgan Chase & Co. reaffirmed a buy rating and set a $69.00 target price on shares of Sensata Technologies in a research report on Tuesday, September 11th. Finally, Morgan Stanley lowered Sensata Technologies from an equal weight rating to an underweight rating and lowered their target price for the stock from $55.00 to $47.00 in a research report on Monday, September 17th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the stock. Sensata Technologies presently has a consensus rating of Hold and an average price target of $59.00.

  • [By Stephan Byrd]

    Canaccord Genuity assumed coverage on shares of Sensata Technologies (NYSE:ST) in a note issued to investors on Friday, The Fly reports. The firm set a “buy” rating on the scientific and technical instruments company’s stock.

Hot Canadian Stocks To Own Right Now: PPL Corporation(PPL)

PPL Corporation, an energy and utility holding company, generates and sells electricity; and delivers natural gas to approximately 5.3 million utility customers primarily in the northeastern and northwestern U.S. The company operates in four segments: Kentucky Regulated, International Regulated, Pennsylvania Regulated, and Supply. The Kentucky Regulated segment engages in the generation, transmission, distribution, and sale of electricity; and the distribution and sale of natural gas to approximately 1.3 million customers in Kentucky, Virginia, and Tennessee. The International Regulated segment owns and operates electricity distribution businesses in the United Kingdom that deliver electricity to 7.7 million customers. The Pennsylvania Regulated segment delivers electricity to approximately 1.4 million customers in eastern and central Pennsylvania. The Supply segment owns and operates power plants to generate electricity using coal, uranium, natural gas, oil, and water res ources; markets and trades electricity and other purchased power to wholesale and retail markets; and acquires and develops domestic generation projects. It controls or owns a portfolio of generation assets of approximately 11,000 megawatts in Montana and Pennsylvania. As of December 31, 2010, the company?s distribution system included 649 substations with a capacity of 25 million kVA, 28,838 circuit miles of overhead lines, and 24,131 cable miles of underground conductors in the United Kingdom. It also operated 377 substations with a capacity of 31 million kVA, 33,122 circuit miles of overhead lines, and 7,368 cable miles of underground conductors in Pennsylvania. The company was founded in 1920 and is headquartered in Allentown, Pennsylvania.

Advisors’ Opinion:

  • [By Shane Hupp]

    PPL (NYSE:PPL) and IDACORP (NYSE:IDA) are both utilities companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.

  • [By Joseph Griffin]

    PNC Financial Services Group Inc. cut its holdings in Pembina Pipeline Corp (NYSE:PBA) (TSE:PPL) by 10.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 74,320 shares of the pipeline company’s stock after selling 9,133 shares during the period. PNC Financial Services Group Inc.’s holdings in Pembina Pipeline were worth $2,205,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    PPL (NYSE:PPL) last issued its quarterly earnings data on Thursday, February 14th. The utilities provider reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.03. The business had revenue of $1.94 billion for the quarter, compared to analyst estimates of $1.88 billion. PPL had a return on equity of 15.23% and a net margin of 19.17%. PPL’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.55 EPS. As a group, research analysts forecast that PPL Corp will post 2.36 EPS for the current year.

    TRADEMARK VIOLATION WARNING: “Commerzbank Aktiengesellschaft FI Has $6.02 Million Holdings in PPL Corp (PPL)” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at www.tickerreport.com/banking-finance/4153395/commerzbank-aktiengesellschaft-fi-has-6-02-million-holdings-in-ppl-corp-ppl.html.

    PPL Profile

Top 5 Canadian Stocks To Invest In 2021

AI Doctor (CURRENCY:AIDOC) traded down 25.3% against the US dollar during the 1-day period ending at 21:00 PM Eastern on July 6th. AI Doctor has a market capitalization of $11.28 million and $3.37 million worth of AI Doctor was traded on exchanges in the last 24 hours. One AI Doctor token can currently be bought for $0.0254 or 0.00000388 BTC on cryptocurrency exchanges including Bibox, BtcTrade.im, Allcoin and BitForex. During the last week, AI Doctor has traded 51.4% higher against the US dollar.

Here’s how other cryptocurrencies have performed during the last 24 hours:

Get AI Doctor alerts:

XRP (XRP) traded down 0.4% against the dollar and now trades at $0.48 or 0.00007256 BTC. Stellar (XLM) traded up 0.5% against the dollar and now trades at $0.20 or 0.00003116 BTC. IOTA (MIOTA) traded 9.3% lower against the dollar and now trades at $1.05 or 0.00015957 BTC. Tether (USDT) traded down 0.4% against the dollar and now trades at $1.00 or 0.00015272 BTC. TRON (TRX) traded 2.5% lower against the dollar and now trades at $0.0367 or 0.00000558 BTC. NEO (NEO) traded 7.6% lower against the dollar and now trades at $36.87 or 0.00561713 BTC. Binance Coin (BNB) traded down 3.2% against the dollar and now trades at $13.42 or 0.00204454 BTC. VeChain (VET) traded 0.9% lower against the dollar and now trades at $2.49 or 0.00037992 BTC. Ontology (ONT) traded down 6.4% against the dollar and now trades at $4.66 or 0.00070982 BTC. Zilliqa (ZIL) traded down 3.2% against the dollar and now trades at $0.0817 or 0.00001244 BTC.

AI Doctor Token Profile

Top 5 Canadian Stocks To Invest In 2021: Stantec Inc(STN)

Stantec Inc. provides professional consulting services in planning, engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics in the areas of infrastructure and facilities for public and private sector clients in North America and internationally. The company involves in the design of healthcare, education, science and technology, airport, retail and commercial, and sports and recreation facilities. Its environmental solutions include water supply, treatment, storage, and distribution; wastewater collection, pumping, treatment, and disposal; watershed management; environmental assessment, documentation, and permitting; ecosystem restoration planning and design; environmental site management and remediation; subsurface investigation and characterization; and geotechnical engineering services. Stantec Inc. also provides industrial planning, functional programming, engineering, project mana gement, and construction support services in oil and gas, fossil and renewable energy, underground mining, linear infrastructure, power transmission and distribution, automotive, forest products, food and beverage, and general manufacturing sectors. In addition, the company prepares transportation master plans for communities; conduct transportation investment studies; plans and designs airport, transit, rail, and highway facilities; and provides administration and support services for the construction of specific projects, and ongoing management planning for the upkeep of transportation facilities, as well as simulation modeling services. Further, it offers urban land solutions for the land development, real estate, and retail and commercial industries, as well as professional services. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canad a.

Advisors’ Opinion:

  • [By Ethan Ryder]

    TRADEMARK VIOLATION NOTICE: “Scotia Capital Inc. Sells 15,249 Shares of Stantec Inc. (STN)” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at www.tickerreport.com/banking-finance/4192654/scotia-capital-inc-sells-15249-shares-of-stantec-inc-stn.html.

  • [By Max Byerly]

    Shares of Stantec Inc. (TSE:STN) (NYSE:STN) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as C$31.96 and last traded at C$31.90, with a volume of 125631 shares trading hands. The stock had previously closed at C$32.18.

  • [By Logan Wallace]

    Stantec Inc. (TSE:STN) (NYSE:STN) – Analysts at National Bank Financial lowered their FY2019 earnings estimates for shares of Stantec in a research report issued to clients and investors on Wednesday, September 12th. National Bank Financial analyst M. Sytchev now anticipates that the company will earn $2.16 per share for the year, down from their previous forecast of $2.20.

Top 5 Canadian Stocks To Invest In 2021: Canadian Imperial Bank of Commerce(CM)

Canadian Imperial Bank of Commerce provides various financial products, services, and advice to individual, small business, commercial, corporate, and institutional clients in Canada and internationally. The company offers retail markets services comprising personal banking, business banking, and wealth management services, as well as investment management services to retail and institutional clients. It also provides wholesale banking services, including credit, capital markets, investment banking, merchant banking, and research products and services to government, institutional, corporate, and retail clients. The company provides its services through its branch network, automated bank machines, mobile banking, and online banking site. As of June 3, 2011, it operated approximately 1,100 branches and 4,000 automated bank machines in Canada. The company was founded in 1867 and is headquartered in Toronto, Canada.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Canadian Imperial Bank of Commerce (NYSE:CM) (TSE:CM) saw unusually large options trading activity on Monday. Traders acquired 2,517 call options on the stock. This is an increase of approximately 3,772% compared to the typical volume of 65 call options.

  • [By Motley Fool Transcribing]

    Canadian Imperial Bank of Commerce (NYSE:CM) Q1 2019 Earnings Conference CallFeb. 28, 2019 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Canadian Imperial Bank of Commerce (CM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Canadian Stocks To Invest In 2021: Credit Suisse Group(CS)

Credit Suisse Group AG, together with its subsidiaries, operates as a financial services company. The company operates in three segments: Private Banking, Investment Banking, and Asset Management. The Private Banking segment offers advisory services and a range of wealth management solutions, including pension planning, life insurance products, tax planning, and wealth and inheritance advice for the high-net-worth and ultra-high-net-worth individuals. This segment also supplies banking products and services to affluent, high-net-worth and ultra-high-net-worth clients, and corporates and institutions. The Investment Banking segment provides investment banking and securities products and services to corporations, governments, pension funds, and institutions. Its products and services include debt and equity underwriting, sales and trading, mergers and acquisitions advice, divestitures, corporate sales, restructuring, and investment research. The Asset Management segment offe rs integrated investment solutions and services to institutions, governments, foundations and endowments, corporations, and individuals. It provides access to a range of investment classes across alternative investment, asset allocation, and traditional investment strategies. The company operates in Switzerland, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. Credit Suisse Group AG was founded in 1856 and is headquartered in Zurich, Switzerland.

Advisors’ Opinion:

  • [By ]

    The ABCs Of IPOs
    Most entities looking to go public bring in underwriters to help navigate the company through the entire process — in Lyft’s case JPMorgan Chase (NYSE: JPM) led the offering along with Credit Suisse Group (NYSE: CS), Jeffries Group LLC and 26 other financial institutions. The filing fees to go public amounted to a staggering $6.5 million for Lyft.

  • [By Shah Gilani]

    Lyft’s lead IPO bankers, JPMorgan Chase & Co. (NYSE: JPM) and Credit Suisse Group AG (NYSE: CS), did a great job of polishing their lead actors’ acting chops.

Top 5 Canadian Stocks To Invest In 2021: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) has a PDUFA action date set for October 5 for its Jemdel (halobetasol propionate 0.01%) (IDP-122) lotion. If approved, Jemdel will be the first high-potency topical steroid treatment for plaque psoriasis with dosing for as long as eight weeks.

  • [By Shane Hupp]

    Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Valeant Pharmaceuticals Intl (VRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    Progenics’ first drug, Relistor for opioid-induced constipation, hasn’t been a big seller, butValeant Pharmaceuticals (NYSE:VRX) has taken over marketing of the drug in return for a reliable royalty stream. This will allow Progenics to focus on Azedra’s potential launch anda prostate cancer imaging agent in late-stage development.

Top 5 Canadian Stocks To Invest In 2021: UniSource Energy Corporation(UNS)

UniSource Energy Corporation engages in the electric generation and energy delivery businesses. The company?s TEP segment generates, transmits, and distributes electricity to approximately 403,000 retail electric customers, including residential, commercial, industrial, and public sector customers in southeastern Arizona. It also sells electricity to other utilities and power marketing entities. As of December 31, 2010, this segment owned or leased 2,245 MW of net generating capacity, as well as owned or participated in electric transmission and distribution system consisting of 512 circuit-miles of 500-kV lines; 1,087 circuit-miles of 345-kV lines; 379 circuit-miles of 138-kV lines; 478 circuit-miles of 46-kV lines; and 2,621 circuit-miles of lower voltage primary lines. TEP segment generates electricity from coal, gas, oil, and solar sources. The company?s UNS Gas segment distributes gas to approximately 146,500 retail customers in Mohave, Yavapai, Coconino, and Navajo c ounties in northern Arizona, as well as Santa Cruz County in southeastern Arizona. As of December 31, 2010, this segment?s transmission and distribution system consisted of approximately 30 miles of steel transmission mains, 4,211 miles of steel and plastic distribution piping, and 136,439 customer service lines. The company?s UNS Electric segment transmits and distributes electricity to approximately 91,000 retail customers consisting of residential, commercial, and industrial customers in Mohave and Santa Cruz counties. As of December 31, 2010, UNS Electric?s transmission and distribution system consisted of approximately 56 circuit-miles of 115-kV transmission lines, 271 circuit-miles of 69-kV transmission lines, and 3,599 circuit-miles of underground and overhead distribution lines. This segment also owns the 65 MW Valencia plant, as well as 39 substations having an installed capacity of 1,788,050 kilovolt amperes. The company was founded in 1902 and is based in Tucson, Arizona.

Advisors’ Opinion:

  • [By Max Byerly]

    Uni Select (TSE:UNS)’s stock had its “hold” rating restated by equities research analysts at TD Securities in a report issued on Friday. They currently have a C$24.00 price objective on the stock. TD Securities’ price target points to a potential upside of 8.21% from the stock’s current price.

  • [By Ethan Ryder]

    Uni Select (TSE:UNS) had its price target lifted by investment analysts at Macquarie from C$24.00 to C$25.00 in a report released on Wednesday. Macquarie’s price objective suggests a potential upside of 18.32% from the stock’s current price.

Best Biotech Stocks To Invest In Right Now

The soccer world may be wondering who will replace Arsenal’s legendary manager Arsene Wenger when he steps down at the end of the season. But first the team could use a good accountant.

Arsenal Football Club, which has gone more than 100 years without being relegated from top-flight English football, may see its short-term financial performance become more volatile than its results on the pitch while it searches for Wenger’s successor, according to Fitch Ratings. Over the long-term, the ratings agency expects a neutral to positive performance by the London-based club, as Arsenal is likely to replace the longtime coach, who managed more Premier League matches than anyone in history and won the league three times, with an experienced manager.

For the fiscal year ended May 31, 2017, Arsenal reported a more than 20 percent increase in revenue to 422.8 million pounds, with pretax profit rising to 44.6 million pounds from 2.9 million pounds the year before, buttressed by the lucrative Premier League TV rights packages.

Best Biotech Stocks To Invest In Right Now: DigitalGlobe, Inc(DGI)

DigitalGlobe is a leading global provider of high-resolution Earth-imagery products and services sourced from our own advanced satellite constellation and third-party providers. Our imagery solutions support a wide variety of users in defense and intelligence, civil agencies, mapping and analysis, environmental monitoring, oil and gas exploration, infrastructure management, Internet portals, and navigation technology. Each day users depend on us to better understand our changing planet in order to save lives, resources and time.

We were originally incorporated as EarthWatch on September 30, 1993 under the laws of the State of Colorado and reincorporated in the State of Delaware on August 21, 1995. On August 22, 2002, we changed our name to DigitalGlobe, Inc. Our common stock has been listed on the New York Stock Exchange (“NYSE”) and traded under the symbol “DGI” since our initial public offering in May 2009.   Advisors’ Opinion:

Best Biotech Stocks To Invest In Right Now: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) has a PDUFA action date set for October 5 for its Jemdel (halobetasol propionate 0.01%) (IDP-122) lotion. If approved, Jemdel will be the first high-potency topical steroid treatment for plaque psoriasis with dosing for as long as eight weeks.

  • [By Shane Hupp]

    Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.

Best Biotech Stocks To Invest In Right Now: Helen of Troy Limited(HELE)

Helen of Troy Limited, together with its subsidiaries, engages in the design, development, import, marketing, and distribution of brand-name consumer products primarily in the United States and Canada, as well as in Europe, Asia, and Latin America. It operates in three segments: Personal Care, Housewares, and Healthcare/Home Environment. The Personal Care segment offers hair dryers, straighteners, curling irons, hair setters, shavers, mirrors, hot air brushes, home hair clippers and trimmers, paraffin baths, massage cushions, footbaths, body massagers, brushes, combs, hair accessories, liquid and aerosol hair styling products, men?s fragrances, men?s and women?s antiperspirants and deodorants, liquid and bar soaps, shampoos, conditioners, hair treatments, foot powder, body powder, and skin care products. The Housewares segment provides kitchen tools, cutlery, bar and wine accessories, household cleaning tools, food storage containers, tea kettles, trash cans, storage an d organization products, hand tools, gardening tools, kitchen mitts and trivets, barbeque tools, and rechargeable lighting products, as well as baby and toddler care products, including convertible high chair. The Healthcare/Home Environment segment offers humidifiers, de-humidifiers, vaporizers, thermometers, air purifiers, fans, portable heaters, heating pads, and electronic mosquito traps. The company sells its products primarily through mass merchandisers, drugstore chains, warehouse clubs, home improvement stores, catalogs, grocery stores, specialty stores, beauty supply retailers, e-commerce retailers, wholesalers, and various types of distributors, as well as directly online to end user consumers. Helen of Troy Limited was founded in 1968 and is based in Hamilton, Bermuda.

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub lowered shares of Helen of Troy (NASDAQ:HELE) from a buy rating to a hold rating in a research report sent to investors on Wednesday.

    HELE has been the topic of several other research reports. Zacks Investment Research downgraded Helen of Troy from a hold rating to a sell rating in a research note on Monday, January 21st. Bank of America set a $151.00 target price on Helen of Troy and gave the company a buy rating in a research note on Monday, November 19th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has an average rating of Buy and a consensus target price of $141.67.

  • [By Logan Wallace]

    Raymond James & Associates lowered its stake in Helen of Troy Limited (NASDAQ:HELE) by 2.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 37,874 shares of the company’s stock after selling 780 shares during the quarter. Raymond James & Associates’ holdings in Helen of Troy were worth $4,968,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Helen of Troy (NASDAQ:HELE) last announced its quarterly earnings results on Tuesday, January 8th. The company reported $2.40 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.16 by $0.24. The business had revenue of $431.10 million during the quarter, compared to analysts’ expectations of $425.76 million. Helen of Troy had a net margin of 12.19% and a return on equity of 18.45%. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.52 EPS. As a group, equities research analysts forecast that Helen of Troy Limited will post 7.03 EPS for the current fiscal year.

    WARNING: “JPMorgan Chase & Co. Has $32.27 Million Position in Helen of Troy Limited (HELE)” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this story can be read at www.tickerreport.com/banking-finance/4129413/jpmorgan-chase-co-has-32-27-million-position-in-helen-of-troy-limited-hele.html.

    About Helen of Troy

  • [By Motley Fool Transcription]

    Helen of Troy Limited (NASDAQ:HELE)Q2 2019 Earnings Conference CallOct. 9, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Value Stocks To Own For 2021

Gold has been a store of value for millennia, and even now, many investors see gold as the ultimate safe haven asset. Yet recently, another precious metal became more valuable than gold — and it’s not the one you might expect.

For a long time, gold and platinum have battled it out for supremacy atop the precious metals markets. Since the 1970s, platinum has usually been worth more than gold, only occasionally dropping beneath the yellow metal’s price for short periods of time. Yet over the past few years, gold prices have surpassed platinum’s, and recently, the price disparity widened to more than $500 before narrowing slightly in the past couple of weeks.

Now, though, a new player has taken over the top spot. Palladium prices have more than doubled since the end of 2016 and are up almost 25% in just the first two months of 2019. That’s sent the rare metal’s price above gold’s for the first time ever.

Data source: Macrotrends. Chart by author.

Hot Value Stocks To Own For 2021: MakeMyTrip Limited(MMYT)

MakeMyTrip Limited, an online travel company, provides travel products and solutions in India and the United States. Its products and services include air tickets, hotels, packages, rail tickets, bus tickets, car hire, and ancillary travel requirements, such as travel insurance and visa processing. The company, through its Website, makemytrip.com, allow travelers to research, plan, and book a range of travel services and products in India and internationally. MakeMyTrip Limited also provides its products and services through other technology-enhanced distribution channels, such as call centers, travel stores, and travel agents? network. Its customers comprise leisure travelers and small businesses. The company was formerly known as International Web Travel Private Limited and changed its name to MakeMyTrip Limited in April 2010. MakeMyTrip Limited was founded in 2000 and is based in Gurgaon, India.

Advisors’ Opinion:

  • [By Logan Wallace]

    MakeMyTrip (NASDAQ:MMYT) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday.

  • [By Max Byerly]

    TheStreet lowered shares of MakeMyTrip (NASDAQ:MMYT) from a c- rating to a d+ rating in a report published on Tuesday.

    Other equities research analysts also recently issued reports about the stock. Jefferies Financial Group raised shares of MakeMyTrip from a hold rating to a buy rating and set a $19.80 price target for the company in a research note on Wednesday, August 15th. BidaskClub downgraded shares of MakeMyTrip from a strong-buy rating to a buy rating in a research note on Wednesday, June 20th. Zacks Investment Research raised shares of MakeMyTrip from a hold rating to a buy rating and set a $45.00 price target for the company in a research note on Friday, June 15th. Bank of America dropped their price target on shares of MakeMyTrip from $40.00 to $39.50 and set a buy rating for the company in a research note on Monday, July 9th. Finally, ValuEngine downgraded shares of MakeMyTrip from a buy rating to a hold rating in a research note on Thursday, September 6th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $36.36.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MakeMyTrip (MMYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Value Stocks To Own For 2021: TTM Technologies, Inc.(TTMI)

TTM Technologies, Inc., incorporated on June 21, 2005, is a manufacturer of printed circuit board (PCB) products and is focused on technologically advanced PCBs and electro-mechanical solutions (E-M Solutions). The Company operates approximately 30 specialized facilities in the United States, the People’s Republic of China (China), Canada and Mexico. The Company’s operating segments include PCB, which consists of approximately 15 domestic PCB fabrication plants, including a facility that provides follow-on value-added services primarily for one of the PCB fabrication plants; over eight PCB fabrication plants in China and one in Canada, and E-M Solutions, which consists of approximately four custom electronic assembly plants; over three in China and one in Mexico. The Company serves a range of customer base in various markets, including manufacturers of networking/communications infrastructure products, smartphones and touchscreen tablets, as well as the aerospace and defense, computing and industrial/medical industries. Its customers include both original equipment manufacturers (OEMs) and electronic manufacturing services (EMS) providers. The Company offers a range of PCB products, including high density interconnect (HDI) PCBs, conventional PCBs, flexible PCBs, rigid-flex PCBs, backplane assemblies and integrated circuits (IC) substrates. It also offers certain services to support its customers’ needs, which include design for manufacturability (DFM) support during new product introduction stages; PCB layout design; simulation and testing services; QTA production, and drilling and routing services.

The Company is focused on high layer count conventional PCBs. A multi-layer PCB can accommodate complex circuitry than a single-sided or double-sided PCB and as such requires more production techniques. The Company’s North America and Asia Pacific operating segments produce HDI PCBs. HDI PCBs are boards with characteristics, including micro-sized holes, or microvias (diameter at or less than ! 0.15 millimeter (mm)), fine lines (circuit line width and spacing at or less than 0.075 mm) and can be constructed with thin high performance materials, thereby enabling interconnection functions per unit area. HDI PCBs generally are manufactured using a sequential build-up process in which circuitry is formed in the PCB one layer at a time through successive drilling, plating and lamination cycles. The Company manufactures circuits on flexible substrates that can be installed in three-dimensional applications for electronic packaging systems. Rigid-flex circuitry provides a means to integrate multiple PCB assemblies and other elements, such as display, input or storage devices without wires, cables or connectors, replacing them with thin, light composites that integrate wiring in ultra-thin, flexible ribbons between sections

The Company assembles backplanes and sub-systems and provides system integration of backplane assemblies, cabling, power, thermal and other complex electromechanical parts into chassis and other enclosures. In addition to assembly services, it provides inspection and testing services, such as automated optical inspection (AOI) and X-ray inspection to ensure that all components have been properly placed and electrical circuits are complete. IC substrates are mounts that are used to connect small ICs to comparatively PCBs for assembly into electronic end products, such as memory modules, cellular phones, digital cameras, automotive global positioning system (GPS) and engine controls. The Company produces and tests circuits used in radio-frequency or microwave emission and collection applications. These products are typically used for radar, transmit/receive antennas and similar wireless applications. The Company also provides custom-fabricated PCBs to customers within 24 hours to 10 days.

The Company competes with Chin Poon Industrial Co., LTD., Unimicron Technology Corp., IBIDEN Co., Ltd., Compeq Manufacturing Co., Ltd., Tripod Technology Corp., ISU Petasys! Co., Ltd! ., Sanmina Corporation, Multek Corporation, Wus Printed Circuit Co., Ltd., Flex, Jabil Circuit, Inc., AT & S Austria Technologie & Systemtechnik AG and Amphenol Corp.

Advisors’ Opinion:

  • [By Ethan Ryder]

    ILLEGAL ACTIVITY WARNING: “Miles Capital Inc. Acquires Shares of 10,416 TTM Technologies, Inc. (TTMI)” was originally published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at www.tickerreport.com/banking-finance/4118880/miles-capital-inc-acquires-shares-of-10416-ttm-technologies-inc-ttmi.html.

  • [By Ethan Ryder]

    TTM Technologies (NASDAQ:TTMI) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Monday.

Hot Value Stocks To Own For 2021: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) has a PDUFA action date set for October 5 for its Jemdel (halobetasol propionate 0.01%) (IDP-122) lotion. If approved, Jemdel will be the first high-potency topical steroid treatment for plaque psoriasis with dosing for as long as eight weeks.

  • [By Shane Hupp]

    Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.

Hot Value Stocks To Own For 2021: Magellan Health Services Inc.(MGLN)

Magellan Health Services, Inc. engages in the specialty managed healthcare business in the United States. The company, through its contracted network of third-party treatment providers, offers managed behavioral healthcare services, including outpatient programs, such as counseling or therapy; intermediate care programs comprising intensive outpatient programs and partial hospitalization services; and inpatient treatment and crisis intervention services. It also provides radiology benefits management services, such as the delivery of diagnostic imaging and other therapeutic services through contracts with health plans and insurance companies, and governmental agencies. In addition, the company offers specialty pharmaceutical management services, including contracting and formulary optimization programs; specialty pharmaceutical dispensing operations; and medical pharmacy management programs. Its specialty pharmaceutical management services are provided under contracts with health plans, insurance companies, employers, and governmental agencies to manage specialty drugs used in the treatment of conditions, such as cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis, and other diseases. Further, the company provides Medicaid administration services comprising pharmacy point-of-sale claims processing systems and administration, drug utilization review, clinical prior authorization, utilization and formulary management services, preferred drug list programs, maximum allowable cost programs, and drug rebate program services under contracts with health plans and public sector healthcare clients for Medicaid and other program recipients. It serves health plans, insurance companies, employers, labor unions, and various governmental agencies. Magellan Health Services, Inc. was founded in 1969 and is based in Avon, Connecticut.

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market was quiet on Wednesday, with different benchmarks reacting to a variety of news events. The release of minutes from the Federal Reserve’s most recent monetary policy meeting generally confirmed what most investors had believed about the central bank’s future course of action, and that helped send the Dow Jones Industrial Average and the S&P 500modestly higher. Yet weakness in key technology stocks caused the Nasdaq Composite to lag its peers. Several stocks posted strong advances, and Garmin (NASDAQ:GRMN), Kandi Technologies Group (NASDAQ:KNDI), and Magellan Health (NASDAQ:MGLN) were among the top performers. Here’s why they did so well.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Magellan Health (MGLN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Value Stocks To Own For 2021: Horizon Global Corporation(HZN)

Horizon Global Corporation, incorporated on January 14, 2015, is a designer, manufacturer and distributor of a range of custom-engineered towing, trailering, cargo management and other related accessory products serving the automotive aftermarket, retail and original equipment (OE) channels. The Company operates through two segments: Cequent Americas and Cequent APEA. The Company’s Cequent Americas and Cequent APEA marketed through original equipment manufacturers (OEMs), OE suppliers, retailers and aftermarket customers servicing users in the agricultural, automotive, construction, horse/livestock, industrial, marine, military, recreational, trailer and utility markets. Its products are used in approximately two primary categories across the world, including commercial applications (Work) and recreational activities (Play). The markets in its Work category include agricultural, automotive, construction, fleet, industrial, marine, military, mining and municipalities. The markets in its Play category include equestrian, power sports, recreational vehicle, specialty automotive, truck accessory and other specialty towing applications. The Company distributes its products through independent installers, warehouse distributors, dealers, OE, retail stores and online retailers.

The Company’s brands include Reese, Hayman-Reese, Draw-Tite, Aqua Clear, Bulldog, BTM, DHF, Engetran, Fulton, Harper, Hidden Hitch, Highland, Kovil, Laitner, Parkside, Pro Series, Reese Secure, Reese Explorer, Reese Power Sports, Reese Towpower, ROLA, Tekonsha, Trojan, WesBarg and Witter Towbar System. The Company has over 6,700 customers across the world. The Company operates manufacturing facilities in Australia, Brazil, Germany, Mexico, New Zealand, South Africa, Thailand and the United Kingdom.

Cequent Americas

The Cequent Americas segment consists of two operating segments: Cequent Performance Products (CPP), a manufacturer of aftermarket and OEM towing and trailering products and accessorie! s, and Cequent Consumer Products (CCP), a provider of towing, trailering, vehicle protection and cargo management solutions serving the end user through retailers. The Cequent Americas segment has operations in North America, and its towing and trailering-related products are sold through retail, aftermarket and OE channels.

Cequent APEA

The Cequent APEA segment focuses its sales and manufacturing efforts outside of the Americas, operating in Australia. The Company also operates in New Zealand, Thailand, Europe, the United Kingdom, South Africa, Germany and Asia Pacific region. It is in the early-stages of its development in these markets focusing on supporting OE customers.

The Company competes with Curt Manufacturing, B&W Trailer Hitches, The Bosal Group, Brink, Westfalia, Buyers Products Company, Demco Products, PullRite, Westin Automotive Products, Camco, Pacific Rim, Dutton-Lainson, Shelby, Ultra-Fab, Sea-Sense, Atwood, Thule, Yakima, Bell, Masterlock and Saris.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Horizon Global (HZN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Horizon Global (HZN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    Horizon Global(NYSE:HZN)reported its second-quarter results on Aug. 7th. Investors had already been provided with a sneak peek at the towing and trailering company’s results in mid-July after management announced that it was expanding its ability to borrow by $50 million. The company’s second-quarter results were largely in line with those updated projections, and management reaffirmed that its turnaround remains on track. However, the year-over-year numbers did not look pretty.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of Horizon Global (NYSE:HZN) from a strong sell rating to a sell rating in a research note released on Wednesday.

    A number of other research firms have also commented on HZN. Zacks Investment Research raised Horizon Global from a strong sell rating to a hold rating in a research report on Thursday, March 29th. B. Riley assumed coverage on Horizon Global in a research report on Friday, April 13th. They issued a buy rating and a $12.50 price target for the company. Bank of America lowered Horizon Global from a buy rating to an underperform rating and lowered their price target for the company from $10.00 to $5.00 in a research report on Friday, June 22nd. Finally, Roth Capital increased their price target on Horizon Global from $6.50 to $7.50 and gave the company a neutral rating in a research report on Friday, June 22nd. Four equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average price target of $13.86.

Top 10 Canadian Stocks To Own Right Now

Canada may be locked in a trade fight with the U.S., but the country’s exporters aren’t slowing down.

According to Markit’s survey of Canadian manufacturers, the index for new export orders hit 55.9 in May, the highest since 2011 and compared with a five-year average of just 51.4. The gauge has risen sharply since the start of the year, suggesting demand for Canadian goods is strengthening.

It’s a timely development, since another report Thursday showed the country’s typically staunch consumers are showing signs of fatigue. Exports may be the just the driver the economy needs to move forward.

#lazy-img-328258092:before{padding-top:56.25%;}

But Friday’s data also adds to evidence Canada’s export manufacturers are reaching their limit. Unless the sector builds more capacity, it’s difficult to imagine how exports — which make up about a third of gross domestic product — can lead growth. In the manufacturing industry, capacity utilization rates, which show how close firms are to maximum output, are currently the highest since 2000.

Top 10 Canadian Stocks To Own Right Now: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Cory Renauer]

    Progenics’ first drug, Relistor for opioid-induced constipation, hasn’t been a big seller, but Valeant Pharmaceuticals (NYSE:VRX) has taken over marketing of the drug in return for a reliable royalty stream. This will allow Progenics to focus on Azedra’s potential launch and a prostate cancer imaging agent in late-stage development.

  • [By Keith Speights]

    Valeant Pharmaceuticals (NYSE:VRX) CEO Joe Papa has said for a while that the company is a great turnaround opportunity. But when the drugmaker reported its 2017 fourth-quarter results in February, it was clear that any turnaround wouldn’t happen quickly.

  • [By Lisa Levin] Gainers
    Integrated Media Technology Limited (NASDAQ: IMTE) rose 30.8 percent to $22.00 in pre-market trading after declining 18.63 percent on Monday.
    Nevsun Resources Ltd. (NYSE: NSU) rose 14.5 percent to $3.40 in pre-market trading after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Sharing Economy International Inc. (NASDAQ: SEII) rose 15.2 percent to $4.25 in pre-market trading after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Veeco Instruments Inc. (NASDAQ: VECO) shares rose 14.1 percent to $19.50 in pre-market trading after reporting stronger-than-expected earnings for its first quarter.
    Impinj, Inc. (NASDAQ: PI) rose 13.4 percent to $15.40 in pre-market trading after reporting Q1 results.
    SandRidge Energy, Inc. (NYSE: SD) shares rose 13.2 percent to $16.45 in pre-market trading following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 12.6 percent to $4.55 in pre-market trading after jumping 171.14 percent on Monday.
    Crocs, Inc. (NASDAQ: CROX) shares rose 10 percent to $16.66 in pre-market trading after the company reported better-than-expected earnings for its first quarter and issued strong sales forecast for the second quarter.
    Pareteum Corporation (NASDAQ: TEUM) rose 9.7 percent to $3.05 in pre-market trading after announcing Q1 results.
    Dean Foods Company (NYSE: DF) rose 8 percent to $9.00 in pre-market trading after reporting upbeat Q1 earnings.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 7.3 percent to $23.45 in pre-market trading following Q1 results.
    IAMGOLD Corporation (NYSE: IAG) rose 7.1 percent to $6.09 in pre-market trading after reporting upbeat Q1 earnings.
    TC PipeLines, LP (NYSE: TCP) rose 6.4 percent to $27 in pre-market trading after gaining 2.08 percent on Monday.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 6.3 percent to $11.75 in pre-market trading fol

Top 10 Canadian Stocks To Own Right Now: 3M Company(MMM)

Advisors’ Opinion:

  • [By Leo Sun]

    Corning’s recent acquisition of 3M’s (NYSE: MMM) optical unit, which is expected to add $200 million to its full-year sales, also boosted the unit’s growth. Corning hiked its full-year sales guidance for the Optical unit from 10% growth to the high teens. Management also reiterated the segment’s long-term goal of generating $5 billion in optical sales by 2020.

  • [By Reuben Gregg Brewer, Chris Neiger, and Travis Hoium]

    Investors today seem to think “long-term” means a quarter or, maybe, a year. But real long-term investors think decades into the future. If that sounds like you, then you want to own safe stocks that you can hold until 2030 — or longer. Three stocks that we think fit the bill today are 3M Company (NYSE:MMM), Apple Inc. (NASDAQ:AAPL), and The Procter & Gamble Company (NYSE:PG). Here’s a quick rundown on why our contributors picked these stocks. 

  • [By Reuben Gregg Brewer]

    The Procter & Gamble Company (NYSE:PG), Hormel Foods Corporation (NYSE:HRL), The Coca-Cola Company (NYSE:KO), Stanley Black & Decker, Inc. (NYSE:SWK), and 3M Company (NYSE:MMM) have all rewarded investors with half a century (or more) worth of consecutive dividend hikes. Here’s why they should be on your buy list, or wish list, today.

  • [By ]

    It’d be one thing if GE were cheap, but on many metrics, it’s not. Many investors at this point would rather pay for United Technologies Corporation (UTX)  , Honeywell International Inc. (HON)  or 3M Co (MMM)  — the last two of which are holdings in Jim Cramer’s Action Alerts PLUS Charitable Trust Portfolio.

  • [By Logan Wallace]

    Sawgrass Asset Management LLC decreased its position in shares of 3M Co (NYSE:MMM) by 29.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,974 shares of the conglomerate’s stock after selling 36,053 shares during the quarter. Sawgrass Asset Management LLC’s holdings in 3M were worth $17,306,000 as of its most recent SEC filing.

  • [By Lee Samaha]

    3M Company’s (NYSE:MMM) rich valuation meant that any kind of growth mishap in 2018 was going to hurt the stock, and that’s just what happened after the company’s recent first-quarter earnings report. That said, after Boeing, 3M Company is the largest industrial company by market cap, and it’s often a good idea to buy into a great company after it stumbles momentarily. So is it now time to buy into the Dividend Aristocrat? Here are four reasons to avoid the stock and two reasons to buy it.

Top 10 Canadian Stocks To Own Right Now: Thor Industries Inc.(THO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Montag A & Associates Inc. acquired a new stake in shares of Thor Industries, Inc. (NYSE:THO) in the 2nd quarter, Holdings Channel reports. The institutional investor acquired 9,875 shares of the construction company’s stock, valued at approximately $962,000.

  • [By Logan Wallace]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) – Equities research analysts at National Bank Financial reduced their FY2018 earnings estimates for shares of Tahoe Resources in a research report issued on Monday, April 9th. National Bank Financial analyst M. Parkin now forecasts that the company will earn $0.29 per share for the year, down from their prior forecast of $0.35. National Bank Financial currently has a “Sector Perform” rating and a $8.00 price objective on the stock.

  • [By Logan Wallace]

    Northcoast Research reaffirmed their buy rating on shares of Thor Industries (NYSE:THO) in a research note published on Friday morning.

    Other research analysts also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Thor Industries from a sell rating to a hold rating in a report on Friday. ValuEngine downgraded shares of Thor Industries from a hold rating to a sell rating in a report on Saturday, May 12th. BMO Capital Markets upgraded shares of Thor Industries from a market perform rating to an outperform rating and set a $102.00 price objective on the stock in a report on Tuesday, May 1st. Sidoti dropped their price objective on shares of Thor Industries from $148.00 to $144.00 and set a buy rating on the stock in a report on Friday, August 10th. Finally, Citigroup dropped their price objective on shares of Thor Industries from $150.00 to $130.00 and set a buy rating on the stock in a report on Thursday, June 21st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the company’s stock. Thor Industries currently has a consensus rating of Buy and a consensus target price of $128.50.

  • [By Garrett Baldwin]

    The system that could make you $104,000 richer in the next 12 months…

    Darden Restaurants Inc. (NYSE: DRI) leads a fairly busy day of earnings reports. The restaurant management giant easily topped Wall Street profit numbers by reporting earnings per share of $1.34. The average Wall Street estimate was $1.23. The firm also easily topped revenue expectations. DRI shares were up 4.5% this morning. The problems continue to mount for General Electric Co. (NYSE: GE). This morning, JPMorgan Securities slashed its price target for the U.S. conglomerate from $11 to $10 per share. The investment firm cited ongoing challenges to the company’s turbine business. General Electric has been under pressure since the financial crisis, and it was the worst performing stock on the Dow in 2017 before it was ultimately replaced on the index. Shares of Under Armour Inc. (NYSE: UAA) added 3.4% this morning, but the driver wasn’t necessarily positive for the global apparel giant. According to reports, the Baltimore-based sports apparel giant is cutting 3% of its international workforce. That equates to roughly 400 jobs. The company did raise its fiscal 2018 earnings forecast, and issued a revised update of severance costs. Look for earnings reports from Micron Technology Inc. (NASDAQ: MU), Thor Industries Inc. (NYSE: THO), United Natural Foods Inc. (NASDAQ: UNFI), Steelcase Inc. (NYSE: SCS), Scholastic Corp. (NASDAQ: SCHL), and Xcerra Corp. (NASDAQ: XCRA).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Steve Symington]

    Shares of Thor Industries Inc. (NYSE:THO) were down 12.8% as of 3:15 p.m. EDT Thursday after the recreational-vehicle specialist announced weaker-than-expected fiscal fourth-quarter 2018 earnings.

Top 10 Canadian Stocks To Own Right Now: Canadian Imperial Bank of Commerce(CM)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Canadian Imperial Bank of Commerce (NYSE:CM)Q2 2018 Earnings Conference CallMay 23, 2018, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Canadian Imperial Bank of Commerce (NYSE:CM) (TSE:CM) saw unusually large options trading activity on Monday. Traders acquired 2,517 call options on the stock. This is an increase of approximately 3,772% compared to the typical volume of 65 call options.

  • [By Joseph Griffin]

    Canadian Imperial Bank of Commerce (NYSE: CM) and Foreign Trade Bank of Latin America (NYSE:BLX) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Top 10 Canadian Stocks To Own Right Now: Airgas Inc.(ARG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Argentum (CURRENCY:ARG) traded 3.6% lower against the US dollar during the one day period ending at 19:00 PM ET on May 27th. In the last week, Argentum has traded 2.8% lower against the US dollar. Argentum has a total market capitalization of $1.66 million and approximately $610.00 worth of Argentum was traded on exchanges in the last day. One Argentum coin can currently be purchased for about $0.17 or 0.00002374 BTC on popular cryptocurrency exchanges including Cryptopia and CoinExchange.

Top 10 Canadian Stocks To Own Right Now: Prestige Brand Holdings Inc.(PBH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Prestige Brands Holdings, Inc. (NYSE:PBH) – Equities researchers at DA Davidson cut their Q2 2019 earnings estimates for shares of Prestige Brands in a research note issued to investors on Tuesday, July 3rd. DA Davidson analyst L. Weiser now anticipates that the company will post earnings per share of $0.60 for the quarter, down from their prior estimate of $0.64. DA Davidson currently has a “Neutral” rating and a $33.00 target price on the stock. DA Davidson also issued estimates for Prestige Brands’ FY2019 earnings at $2.83 EPS and FY2020 earnings at $2.97 EPS.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of Prestige Brands Holdings, Inc. (NYSE:PBH) have been assigned a consensus recommendation of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $71.40.

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Stephan Byrd]

    Shares of Prestige Brands Holdings, Inc. (NYSE:PBH) have been assigned a consensus recommendation of “Hold” from the ten brokerages that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $73.80.

Top 10 Canadian Stocks To Own Right Now: Apollo Gold Corporation(BRD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Bread (CURRENCY:BRD) traded 10.1% lower against the U.S. dollar during the 24-hour period ending at 15:00 PM ET on May 6th. Bread has a market cap of $73.13 million and approximately $1.09 million worth of Bread was traded on exchanges in the last 24 hours. One Bread token can currently be purchased for about $0.82 or 0.00008683 BTC on popular exchanges including OKEx, Binance and Cobinhood. In the last seven days, Bread has traded 3.3% higher against the U.S. dollar.

  • [By Max Byerly]

    Bread (CURRENCY:BRD) traded up 0.8% against the US dollar during the twenty-four hour period ending at 22:00 PM Eastern on September 1st. Over the last week, Bread has traded 3.1% higher against the US dollar. Bread has a market cap of $32.33 million and $367,357.00 worth of Bread was traded on exchanges in the last day. One Bread token can currently be purchased for about $0.36 or 0.00005097 BTC on major cryptocurrency exchanges including Kucoin, Cobinhood, Binance and OKEx.

  • [By Max Byerly]

    Bread (CURRENCY:BRD) traded 0% higher against the US dollar during the 24 hour period ending at 0:00 AM E.T. on February 12th. Bread has a market capitalization of $17.44 million and $74,926.00 worth of Bread was traded on exchanges in the last day. In the last week, Bread has traded 6.8% higher against the US dollar. One Bread token can currently be purchased for $0.20 or 0.00005397 BTC on major cryptocurrency exchanges including Cobinhood, OKEx, Tokenomy and Kucoin.

Top 10 Canadian Stocks To Own Right Now: Stantec Inc(STN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Stantec (STN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Stantec (NYSE: STN) and VSE (NASDAQ:VSEC) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Stantec (STN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Canadian Stocks To Own Right Now: Sensata Technologies Holding N.V.(ST)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Sensata Technologies (ST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Canaccord Genuity assumed coverage on shares of Sensata Technologies (NYSE:ST) in a note issued to investors on Friday, The Fly reports. The firm set a “buy” rating on the scientific and technical instruments company’s stock.

  • [By Max Byerly]

    Sensata Technologies (NYSE:ST) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $3.94-4.10 for the period, compared to the Thomson Reuters consensus estimate of $4.05. The company issued revenue guidance of $3.58-3.68 billion, compared to the consensus revenue estimate of $3.63 billion.Sensata Technologies also updated its FY 2019 guidance to $3.94-4.10 EPS.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Sensata Technologies (ST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Canadian Stocks To Own Right Now: PPL Corporation(PPL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “PPL (PPL) Issues FY 2021 Earnings Guidance” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at www.tickerreport.com/banking-finance/4152309/ppl-ppl-issues-fy-2021-earnings-guidance.html.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $30.81 after closing Friday at $31.13. The 52-week high is $40.20. Volume was about 3.5 million, about 25% below the daily average of around 4.5 million shares. The electric utility company had no specific news.

  • [By ]

    2) Review your goals. Are you retired and managing your portfolio for income and realize you’re loaded up with low- to no-yield growth stocks? It’s time to make some adjustments. As the second half of the year encounters choppier waters, many equity strategists have recommended reducing risk by pivoting toward more defensive stocks in sectors such as pharmaceuticals, utilities, and consumer staples. Some great names that are currently trading at attractive levels include health care giant Johnson & Johnson (NYSE: JNJ), power producer PPL Corp (NYSE: PPL) and food giant General Mills (NYSE: GIS). Weighted equally, all three yield an average of 4.3% and trade with a forward PE of just 14.17.

  • [By Ethan Ryder]

    Pembina Pipeline Corp (TSE:PPL) (NYSE:PBA) insider Cameron Goldade sold 2,000 shares of the business’s stock in a transaction dated Thursday, September 20th. The shares were sold at an average price of C$25.96, for a total value of C$51,920.00.